Literature DB >> 25475150

Baló's concentric sclerosis and tumefactive demyelination: a shared immunopathogenesis?

Todd A Hardy1, Heidi N Beadnall2, Ian J Sutton3, Armin Mohamed4, Benjamin P Jonker5, Michael E Buckland6, Michael H Barnett7.   

Abstract

Baló's concentric sclerosis (BCS) and tumefactive demyelination (TD) are considered atypical forms of multiple sclerosis (MS). Baló lesions are characterized by concentric rings corresponding to alternating bands of demyelination and relatively preserved myelin (Hu and Lucchinetti, 2009). Tumefactive lesions are pseudotumoural demyelinating lesions of >2 cm and may have an open ring-enhancing magnetic resonance imaging appearance (Hu and Lucchinetti, 2009; Lucchinetti et al., 2008; Altintas et al., 2012). We present a patient who developed limb weakness and focal seizures secondary to a lesion radiologically and histopathologically consistent with BCS who, six months later, developed a tumefactive demyelinating lesion. This is the first description of BCS and TD occurring in the same patient and is particularly notable because of the lack of any other more typical demyelinating lesions on the MRIs. The nature of BCS and TD in relation to more typical multiple sclerosis is discussed.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atypical; Multiple sclerosis; Neuroinflammation; Pseudotumour; Tumour-like

Mesh:

Year:  2014        PMID: 25475150     DOI: 10.1016/j.jns.2014.11.024

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?

Authors:  Anna M Pietroboni; Andrea Arighi; Milena A De Riz; Laura Ghezzi; Alberto Calvi; Sabrina Avignone; Elisa Scola; Daniela Galimberti; Fabio Triulzi; Elio Scarpini
Journal:  Neurol Sci       Date:  2015-06-25       Impact factor: 3.307

2.  Heterogeneity of Baló's concentric sclerosis: a study of eight cases with different therapeutic concepts.

Authors:  D Tzanetakos; A G Vakrakou; J S Tzartos; G Velonakis; M E Evangelopoulos; M Anagnostouli; G Koutsis; E Dardiotis; E Karavasilis; P Toulas; L Stefanis; C Kilidireas
Journal:  BMC Neurol       Date:  2020-11-02       Impact factor: 2.474

Review 3.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.